Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01782586 · ClinicalTrials.gov registry record
Validation of Gene Expression Markers of Renal Allograft Functional Decline
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 499
- Enrollment target
NCT01782586 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 499 participants.
The verdict
NCT01782586 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 499 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if certain genes found in a kidney biopsy performed at one-year post transplant can predict which transplanted kidneys will have decreased kidney function within five years post-transplant.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 499 participants |
| Start Date | 2013-03 |
| Est. Completion | 2018-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01782586
The ClinicalTrials.gov registry entry for NCT01782586 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 499 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01782586 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01782586 about?
NCT01782586 is a clinical study titled "Validation of Gene Expression Markers of Renal Allograft Functional Decline". The purpose of this study is to determine if certain genes found in a kidney biopsy performed at one-year post transplant can predict which transplanted kidneys will have decreased kidney function within five years post-transplant.
What is the current status of trial NCT01782586?
This trial is currently completed. The enrollment target is 499 participants. The study started on 2013-03. Estimated completion is 2018-03.
Who is sponsoring clinical trial NCT01782586?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.